Difference between revisions of "Profiles"

Revision as of 19:24, 26 May 2017

Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.

How to use QIBA Profiles
Biomarker Committee pages may also have links to DRAFT Profile documents for the next Stage.
Profile Conformance describes how sites and products claim conformance to a Profile.
QIBA Profile Template shows the structure, rationale and content of a Profile (show "All Markup" to see guidance in the Word comments)

@@ Line 13: / Line 13: @@
 * [[Media:QIBADWIProfilev1.45_20170427_v5_accepted_linenumbers.pdf| DWI Profile 2017-04-27]] (Public Comment Form: https://goo.gl/fkL6rB)
 * [[Media:DCEMRIProfile v1 6-20111213.pdf|DCE-MRI Quantification 2011-12-13]] (''Public Comment ended Feb 2012'')
-*[[Media:001.QIBA SPECT Profile.v0.1 2016.10.28.docx | QIBA Profile: Quantifying Dopamine Transporters with 123 - Iodine Labeled Ioflupane in Neurodegenerative Disease Profile (v1.0), October 28, 2016]]
+*[[Media:001.QIBA SPECT Profile.v0.1 2016.10.28.docx | Quantifying Dopamine Transporters with 123 - Iodine Labeled Ioflupane in Neurodegenerative Disease Profile (v1.0), October 28, 2016]]
-:*[[Media:002.QIBA SPECT Profile Checklist Extract.2016 10 31.docx|QIBA Profile Checklist: SPECT Profile Conformance]]
+:*[[Media:002.QIBA SPECT Profile Checklist Extract.2016 10 31.docx|Checklist: SPECT Profile Conformance]]
 ==Statements of Endorsement==